LH vs ABBV
Based on Invest's signal, Labcorp Holdings Inc. (LH) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus hold for ABBV.
| Metric | LH | ABBV |
|---|---|---|
| Price | $296.77 | $259.36 |
| Day change | +2.0% | +0.9% |
| Market cap | $24.3B | $458.2B |
| P/E ratio | 26.3 | 127.8 |
| 1-year return | +18.5% | +36.1% |
| Invest signal | Buy | Hold |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying LH and ABBV at live prices.
LH vs ABBV: FAQ
Is LH or ABBV the better stock to buy?
Based on Invest's signal, Labcorp Holdings Inc. (LH) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus hold for ABBV. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, LH or ABBV?
ABBVIE INC. is the larger company by market capitalisation ($458.2B vs $24.3B).
Can I practice trading LH and ABBV for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both LH and ABBV at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.